New gene therapy targets Parkinson's in patients with specific genetic mutation
NCT ID NCT07414290
First seen Feb 18, 2026 · Last updated May 23, 2026 · Updated 11 times
Summary
This early-stage study tests a gene therapy called VGN-R08b in 17 people with Parkinson's disease who have a specific genetic change (GBA1 mutation). The treatment is given as an injection into the fluid around the brain. The main goals are to check safety and see if it can improve symptoms or disease markers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (PD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Xiangya Hospital, Central South University
Changsha, Hunan, 410008, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.